icad inc Total Assets
icad inc total assets. Based on the latest financial reports, icad inc (ICAD) holds total assets worth $39.47 Million USD as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ICAD stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of icad inc (1987–2024)
Total assets of icad inc from 1987 to 2024. This chart illustrates how icad inc's total assets have evolved over time, based on quarterly financial data. See today's stock price for icad inc for real-time trading data and today's change.
icad inc - Asset Composition Analysis
icad inc Total Assets Breakdown (December 2024)
icad inc total assets breakdown as of December 2024. icad inc's total assets of $39.47 Million consist of 70.4% current assets and 29.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 45.8% |
| Accounts Receivable | $7.21 Million | 19.2% |
| Inventory | $756.00K | 2.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $101.00K | 0.3% |
| Goodwill | $8.36 Million | 22.3% |
Asset Composition Trend (1987–2024)
This chart illustrates how icad inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of icad inc to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: icad inc's current assets represent 70.4% of total assets in 2024, an increase from 46.7% in 1987.
- Cash Position: Cash and equivalents constituted 45.8% of total assets in 2024, up from 1.1% in 1987.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, a decrease from 33.0% in 1987.
- Asset Diversification: The largest asset category is goodwill at 22.3% of total assets.
icad inc Competitors by Total Assets
Key competitors of icad inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
icad inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.66 | 4.71 | 2.79 |
| Quick Ratio | 3.57 | 4.59 | 2.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $20.43 Million | $22.88 Million | $22.90 Million |
icad inc - Advanced Valuation Insights
This section examines the relationship between icad inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.45 |
| Latest Market Cap to Assets Ratio | 2.83 |
| Asset Growth Rate (YoY) | -9.4% |
| Total Assets | $37.54 Million |
| Market Capitalization | $106.31 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values icad inc's assets at a significant premium (2.83x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: icad inc's assets decreased by 9.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for icad inc (1987–2024)
The table below shows the annual total assets of icad inc from 1987 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $37.54 Million | -9.36% |
| 2023-12-31 | $41.42 Million | -19.90% |
| 2022-12-31 | $51.70 Million | -16.86% |
| 2021-12-31 | $62.19 Million | +11.89% |
| 2020-12-31 | $55.58 Million | +33.14% |
| 2019-12-31 | $41.75 Million | +31.54% |
| 2018-12-31 | $31.74 Million | -1.23% |
| 2017-12-31 | $32.13 Million | -16.87% |
| 2016-12-31 | $38.65 Million | -20.54% |
| 2015-12-31 | $48.64 Million | -48.13% |
| 2014-12-31 | $93.77 Million | +59.16% |
| 2013-12-31 | $58.92 Million | -1.80% |
| 2012-12-31 | $59.99 Million | +15.90% |
| 2011-12-31 | $51.76 Million | -44.95% |
| 2010-12-31 | $94.03 Million | +28.09% |
| 2009-12-31 | $73.41 Million | +0.30% |
| 2008-12-31 | $73.19 Million | +18.56% |
| 2007-12-31 | $61.73 Million | +2.39% |
| 2006-12-31 | $60.29 Million | -2.01% |
| 2005-12-31 | $61.53 Million | -5.54% |
| 2004-12-31 | $65.14 Million | +3.95% |
| 2003-12-31 | $62.66 Million | +140.29% |
| 2002-12-31 | $26.08 Million | +526.69% |
| 2001-12-31 | $4.16 Million | -30.02% |
| 2000-12-31 | $5.95 Million | +4.31% |
| 1999-12-31 | $5.70 Million | -10.94% |
| 1998-12-31 | $6.40 Million | -9.86% |
| 1997-12-31 | $7.10 Million | -44.53% |
| 1996-12-31 | $12.80 Million | -30.81% |
| 1995-12-31 | $18.50 Million | -14.35% |
| 1994-12-31 | $21.60 Million | +19.34% |
| 1993-12-31 | $18.10 Million | -7.65% |
| 1992-12-31 | $19.60 Million | +29.80% |
| 1991-12-31 | $15.10 Million | -31.05% |
| 1990-12-31 | $21.90 Million | -5.19% |
| 1989-12-31 | $23.10 Million | +22.22% |
| 1988-12-31 | $18.90 Million | +110.00% |
| 1987-12-31 | $9.00 Million | -- |
About icad inc
iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurat… Read more